Document N7K3exKBn7VpvxwDzgnV6wyR

REYNOLDS--BERYLLIUM DISEASE FROM CERAMIC INDUSTRY 577 a ioo p 80 vital CAPACITV.CC. IMPROVEMENT TOXICITY 60 M 60 TG H* 0 20 10 3 4 6 0 10 12 14 16 10 2022 24 2620 30 I 3 5 7 9 II 13 IS 17 19 21 23 2527 29 14 16 18 20 22 24 26 9 II 13 15 17 19 21 ( MAY 1950 JUNE AUG. SEPT. Chart 2.--Observations recorded during the patient's third and final hospitalization, under the first and second periods of ACTH therapy. In the column headed "Improvement" 0.0.B, means out of bed. EOS. 50*400 426*80*98 * 50 * CL 450*500 NA 320*350 CHOL. 150*250 SUG. 00*120 HOT. 35*45 SED. <20 K 16*22 UREA 15*40 CA 9*11 T.P 6*8 Vo URIC A.I-5 CHEAT J-g -2 URINE % iM 80*309*32*0 -20*78*110 * 20*133*36 -189 -126 !^8 V^.4 3 4 6 6 10 12 14 16 16 202224262630 1 3 .3 7 9 II 13 IS 17 19 21 23 23'27 29 14 16 16 20 22 24 26 MAY 1950 JUNE AUG: 9-11 13 13 17 19 21 -SEPT. Chart 3.--Laboratory data recorded during the first, second and third periods of ACTH therapy. A '> . fK- - l' {" 41 i f F_.,' U. 4) l' 1 Iii i*' ' *